FDA Approves Bimzelx (bimekizumab-bkzx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis
October 18, 2023FDA Approves Cabtreo (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris
October 20, 2023October 19, 2023 - Apotex Corp.; Sun Pharmaceutical Industries, Inc.; Teva Pharmaceuticals USA, Inc., have been approved by the FDA for the use of Pazopanib Hydrochloride Tablets (200 mg/base) for treatment of Renal Cell Carcinoma; Soft Tissue Sarcoma. This approval is as a generic to Votrient.